BioNTech SE (BNTX)

BioNTech SE Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 20, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Market Capitalization	22,436	22,891	27,318	25,088	36,506	62,264
Market Cap Growth	-15.56%	-16.20%	8.89%	-31.28%	-41.37%	217.21%
Enterprise Value	6,617	6,134	8,954	8,633	23,607	59,821
Last Close Price	89.27	95.20	113.95	105.54	150.22	255.33
PE Ratio	-	-	-	24.40	3.62	5.32
Forward PE	-	-	-	67.81	8.27	8.07
PS Ratio	6.66	6.79	9.59	5.94	1.97	2.89
PB Ratio	0.99	1.01	1.36	1.12	1.70	4.60
P/TBV Ratio	1.11	1.13	1.45	1.19	1.72	4.68
P/FCF Ratio	69.02	69.41	-	4.43	2.58	71.83
P/OCF Ratio	41.90	42.76	127.04	4.23	2.52	61.54
EV/Sales Ratio	1.96	1.82	3.14	2.05	1.28	2.77
EV/EBITDA Ratio	-	-	-	7.04	1.84	3.53
EV/EBIT Ratio	-	-	-	8.04	1.85	3.54
EV/FCF Ratio	20.36	18.60	-	1.53	1.67	69.01
Debt / Equity Ratio	0.01	0.01	0.01	0.01	0.01	0.03
Debt / EBITDA Ratio	-	-	-	0.19	0.02	0.02
Debt / FCF Ratio	0.95	0.95	-	0.04	0.02	0.40
Net Debt / Equity Ratio	-0.70	-0.70	-0.80	-0.81	-0.69	-0.15
Net Debt / EBITDA Ratio	11.99	11.99	13.27	-14.71	-1.16	-0.12
Net Debt / FCF Ratio	-47.96	-47.96	197.84	-3.19	-1.05	-2.33
Asset Turnover	0.13	0.13	0.12	0.17	0.89	2.09
Inventory Turnover	3.10	3.10	1.69	1.51	6.36	10.28
Quick Ratio	6.87	6.87	6.88	9.12	7.19	4.15
Current Ratio	7.54	7.54	7.45	9.43	7.43	4.33
Return on Equity (ROE)	-5.88%	-5.88%	-3.36%	4.62%	59.06%	155.18%
Return on Assets (ROA)	-3.56%	-3.56%	-3.53%	2.62%	38.09%	102.25%
Return on Invested Capital (ROIC)	-25.47%	-26.47%	-33.23%	15.07%	106.34%	195.58%
Return on Capital Employed (ROCE)	-6.40%	-6.40%	-6.40%	4.60%	58.60%	120.20%
Earnings Yield	-5.95%	-5.83%	-2.52%	4.10%	27.62%	18.80%
FCF Yield	1.45%	1.44%	-0.30%	22.56%	38.78%	1.39%
Buyback Yield / Dilution	-0.54%	-0.54%	0.95%	2.84%	3.81%	-4.51%

Updated Mar 10, 2026. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q